Abstract:Background: Foam cells are characteristic pathologic cells of atherosclerosis (AS), they are lipid-loaded macrophages present on atherosclerotic lesions. A large number of studies has shown that the pathogenesis of AS is the result of interactions between the lipid metabolism disorders and chronic inflammatory responses in the body. Albiflorin can inhibit the inflammatory response and it has shown a therapeutic effect on certain inflammatory diseases. Methods: In this study, a human acute monocytic leukemia cell line (THP-1)-derived foam cell model was established via oxidized low-density lipoprotein (ox-LDL) to observe the effects of albiflorin on the AS-characteristic foam cells. Results: Our results showed that, after the treatment with ox-LDL, macrophages induced by propylene glycol methyl ether acetate (PMA), presented large amounts of lipid deposition in their cytoplasm, indicating that the THP-1-derived foam cell model was successfully established. On the other hand, the same cells pretreated with albiflorin presented significantly reduced amounts of lipid deposition, and their contents of total cholesterol and triglyceride were also clearly lower. Besides, the expression levels of low-density lipoprotein receptor-1 (LOX-1) and nuclear factor-κB (NF-κB) were significantly decreased, and the expression levels of downstream factors interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were also obviously decreased in the cells treated with albiflorin but not in the negative control cells. Moreover, after treatment of macrophages with different concentrations of ox-LDL, the expression levels of LOX-1 and NF-κB were up-regulated in an ox-LDL concentration-dependent manner, and so were the expression levels of IL-6 and TNF-α. And, it was found after treatment with LOX-1 neutralizing antibody or NF-κB inhibitor (during the foam cell formation induction via ox-LDL) that the lipid deposition in the cytoplasm of the cells was reduced, as in the cells treated with albiflorin. Conclusions: Taken together, our findings suggest that albiflorin decreases lipid deposition in the cytoplasm and blocks the foaming process by regulating the LOX-1/NF-κB signaling pathway.

Recombinant Klotho Protein Enhances Cholesterol Efflux of THP-1 Macrophage-Derived Foam Cells Via Suppressing Wnt/β-catenin Signaling Pathway

Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1

7-Ketocholesterol Promotes Cholesterol Uptake and Inflammation in Macrophage: Potential Mechanisms of Dietary COP in Atherosclerosis Promotion

Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE.

Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARγ-LXRα-ABCA1-dependent pathway associated with apoE

Apelin-13 Impedes Foam Cell Formation by Activating Class Iii Pi3k/Beclin-1-Mediated Autophagic Pathway

CTRP1 decreases ABCA1 expression and promotes lipid accumulation through the miR‐424‐5p/FoxO1 pathway in THP‐1 macrophage‐derived foam cells

Apelin-13 Increases Expression of ATP-binding Cassette Transporter A1 Via Activating Protein Kinase C Α Signaling in THP-1 Macrophage-Derived Foam Cells.

Triterpenoid-Enriched Extract of Ilex Kudingcha Inhibits Aggregated Ldl-Induced Lipid Deposition in Macrophages by Downregulating Low Density Lipoprotein Receptor-Related Protein 1 (Lrp1)

LCK inhibitor attenuates atherosclerosis in ApoE -/- mice via regulating T cell differentiation and reverse cholesterol transport.

Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio

CKIP-1 Limits Foam Cell Formation and Inhibits Atherosclerosis by Promoting Degradation of Oct-1 by REGγ

PLK1 promotes cholesterol efflux and alleviates atherosclerosis by up-regulating ABCA1 and ABCG1 expression via the AMPK/PPARγ/LXRα pathway.

Crocin ameliorates atherosclerosis by promoting the reverse cholesterol transport and inhibiting the foam cell formation via regulating PPARγ/LXR-α

TGF-&beta;1 Up-Regulates Expression of ABCA1, ABCG1 and SR-BI Through Liver X Receptor &alpha; Signaling Pathway in THP-1 Macrophage-Derived Foam Cells

Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell Formation

Albiflorin inhibits the formation of THP-1-derived foam cells through the LOX-1/NF-κB pathway

Apolipoprotein AⅠInhibits Lipid Retention and Apoptosis in Foam Cells via Induction of Autophagy

Proteomic analysis reveals the mechanisms of the astaxanthin suppressed foam cell formation

Reduction of Intracellular Chloride Concentration Promotes Foam Cell Formation

LCK inhibitor attenuates atherosclerosis in <i>ApoE</i><SUP>-/-</SUP> mice via regulating T cell differentiation and reverse cholesterol transport